China NMPA Product Recall - Knee prosthesis (trade name: NexGen)

On May 4, 2015, the National Medical Products Administration (NMPA) of China published an index concerning a voluntary recall initiated by Zimmer Inc. of the United States. The recall, reported by its distributor, Zimmer (Shanghai) Medical International Trading Co., Ltd., pertained to NexGen knee prostheses (Registration Certificate No.: CFDA (Imported) 2012 No. 3462713). The primary issue identified was the presence of potentially contaminated nails within the product packaging. The manufacturer confirmed that the recalled products were not sold in the Chinese market. Under the NMPA's regulatory framework, this action underscores a commitment to product quality and patient safety. In response, the NMPA mandated that food and drug administrations across all Chinese provinces, autonomous regions, and municipalities strengthen their supervision of similar medical devices. This measure aims to proactively monitor product safety, even for items not directly sold domestically but registered or distributed by local entities.